https://doi.org/10.4081/reumatismo.2018.1106
Extra-articular rheumatoid arthritis
Accepted: 14 March 2018
All claims expressed in this article are solely those of the authors and do not necessarily represent those of their affiliated organizations, or those of the publisher, the editors and the reviewers. Any product that may be evaluated in this article or claim that may be made by its manufacturer is not guaranteed or endorsed by the publisher.
Authors
Rheumatoid arthritis (RA) is a chronic inflammatory disease that mainly affects the joints, though a consistent proportion of patients may also display extra articular manifestations (EAMs). From rheumatoid nodules to interstitial lung disease, from cardiovascular events to vasculitis, the spectrum of EAMs encompasses various conditions with different prognoses. EAMs may also occur as first RA manifestation, therefore the coordination with other health professionals, including general practitioners, is needed. The aim of this article is to provide an overview on EAMs in RA with particular focus on the recognised risk factors and the available recommendations for managing them, as well as comorbidities in RA patients.
How to Cite
Authors who publish with this journal agree to the following terms:
- Authors retain copyright and grant the journal right of first publication with the work simultaneously licensed under a Creative Commons Attribution License that allows others to share the work with an acknowledgement of the work's authorship and initial publication in this journal.
- Authors are able to enter into separate, additional contractual arrangements for the non-exclusive distribution of the journal's published version of the work (e.g., post it to an institutional repository or publish it in a book), with an acknowledgement of its initial publication in this journal.
- Authors are permitted and encouraged to post their work online (e.g., in institutional repositories or on their website) prior to and during the submission process, as it can lead to productive exchanges, as well as earlier and greater citation of published work.
Similar Articles
- M. Rossini, D. Gatti, O. Viapiana, C. Caimmi, L. Idolazzi, E. Fracassi, S. Adami, Vitamin D and rheumatic diseases , Reumatismo: Vol. 66 No. 2 (2014)
- E. Catarsi, M. Doveri, A. Tavoni, Bosentan and sildenafil: successful treatment in a sclerodermic patient with refractory ulcers , Reumatismo: Vol. 65 No. 2 (2013)
- I. Bertoldi, B. Frediani, Osteoarthritis and osteoporosis: correlations between two clinical entities , Reumatismo: Vol. 65 No. 2 (2013)
- S. Loffredo, F. Ayala, G.C. Marone, A. Genovese, G. Marone, IMMUNOPATHOGENESIS OF PSORIASIS AND PSORIATIC ARTHRITIS AND PHARMACOLOGICAL PERSPECTIVES , Reumatismo: Vol. 59 No. s1 (2007)
- A. Corrado, F.P. Cantatore, Dupuytren’s disease. State of the art and therapeutic perspectives , Reumatismo: Vol. 59 No. 2 (2007)
- H. Semiz, M. Yalcin, S. Kobak, Coexistence of sarcoidosis and Hashimoto thyroiditis , Reumatismo: Vol. 70 No. 2 (2018)
- S. Muller, S. Hider, T. Helliwell, R. Partington, C. Mallen, The real evidence for polymyalgia rheumatica as a paraneoplastic syndrome , Reumatismo: Vol. 70 No. 1 (2018): Monographic issue on Polymyalgia Rheumatica
- W.A. Wan Asyraf, M.S. Mohd Shahrir, W. Asrul, A.W. Norasyikin, O. Hanita, W.Y. Kong, M.T. Azmi, The association between serum prolactin levels and interleukin-6 and systemic lupus erythematosus activity , Reumatismo: Vol. 70 No. 4 (2018)
- A. Lo Gullo, G. Mandraffino, C.O. Aragona, A. Molica Colella, A. Saitta, E. Imbalzano, Subcutaneous administration of tocilizumab is effective in myointimal hyperplasia remodelling in refractory Takayasu arteritis , Reumatismo: Vol. 69 No. 4 (2017)
- F. Saccon, M. Gatto, M. Larosa, F. Ometto, M. Felicetti, R. Padoan, M. Zen, Diagnostic and prognostic role of renal histopathology in rheumatic diseases , Reumatismo: Vol. 70 No. 3 (2018): Monographic issue on Histopathology in Rheumatic Diseases
<< < 24 25 26 27 28 29 30 31 32 33 > >>
You may also start an advanced similarity search for this article.
